BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 14579355)

  • 1. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model of a ternary complex between activated factor VII, tissue factor and factor IX.
    Chen SW; Pellequer JL; Schved JF; Giansily-Blaizot M
    Thromb Haemost; 2002 Jul; 88(1):74-82. PubMed ID: 12152682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J; Perera L; Stafford D; Pedersen L
    J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
    Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
    Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
    Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
    J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicted solution structure of zymogen human coagulation FVII.
    Perera L; Darden TA; Pedersen LG
    J Comput Chem; 2002 Jan; 23(1):35-47. PubMed ID: 11913388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential coagulation factor VIIa domain binding to tissue factor.
    Osterlund M; Persson E; Carlsson U; Freskgård PO; Svensson M
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1276-82. PubMed ID: 16236263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
    Thiec F; Cherel G; Christophe OD
    J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor.
    Carlsson K; Freskgård PO; Persson E; Carlsson U; Svensson M
    Eur J Biochem; 2003 Jun; 270(12):2576-82. PubMed ID: 12787023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
    Jiang X; Guo YL; Bromberg ME
    Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
    Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
    J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E; St Charles R; Tulinsky A
    J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
    Carlsson K; Persson E; Carlsson U; Svensson M
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of the N-terminal EGF-like domain from human factor VII.
    Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
    Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An all-atom solution-equilibrated model for human extrinsic blood coagulation complex (sTF-VIIa-Xa): a protein-protein docking and molecular dynamics refinement study.
    Venkateswarlu D; Duke RE; Perera L; Darden TA; Pedersen LG
    J Thromb Haemost; 2003 Dec; 1(12):2577-88. PubMed ID: 14750502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent estimates of the structure of the factor VIIa (FVIIa)/tissue factor (TF) and factor Xa (FXa) ternary complex.
    Lee CJ; Chandrasekaran V; Wu S; Duke RE; Pedersen LG
    Thromb Res; 2010 Apr; 125 Suppl 1():S7-S10. PubMed ID: 20156644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.
    Osterlund M; Persson E; Svensson M; Carlsson U; Freskgård PO
    Biochem Biophys Res Commun; 2005 Feb; 327(3):789-93. PubMed ID: 15649415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.
    Freskgård PO; Olsen OH; Persson E
    Protein Sci; 1996 Aug; 5(8):1531-40. PubMed ID: 8844844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
    Ndonwi M; Broze G; Bajaj SP
    J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.